Sumitomo Mitsui Trust Holdings, Inc. Incyte Corp Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$134 Billion
Q2 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 533,194 shares of INCY stock, worth $35.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

533,194

Previous 625,450 14.75%

Holding current value

$35.1 Million

Previous $35.6 Million 9.29%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$51.18 - $63.75 $4.72 Million - $5.88 Million	-92,256 Reduced 14.75%	533,194 $32.3 Million
Q1 2024 Apr 19, 2024	SELL	$56.55 - $66.59 $2.17 Million - $2.56 Million	-38,443 Reduced 5.79%	625,450 $35.6 Million
Q4 2023 Jan 30, 2024	SELL	$52.16 - $64.19 $377,794 - $464,928	-7,243 Reduced 1.08%	663,893 $41.7 Million
Q3 2023 Oct 30, 2023	BUY	$57.77 - $65.93 $799,883 - $912,866	13,846 Added 2.11%	671,136 $38.8 Million
Q2 2023 Jul 31, 2023	SELL	$60.95 - $75.51 $5.7 Million - $7.06 Million	-93,476 Reduced 12.45%	657,290 $40.9 Million
Q1 2023 Apr 27, 2023	BUY	$70.23 - $86.01 $380,014 - $465,400	5,411 Added 0.73%	750,766 $54.3 Million
Q4 2022 Jan 30, 2023	SELL	$67.18 - $84.11 $2.19 Million - $2.75 Million	-32,657 Reduced 4.2%	745,355 $59.9 Million
Q3 2022 Oct 21, 2022	BUY	$66.18 - $82.86 $457,700 - $573,059	6,916 Added 0.9%	778,012 $51.8 Million
Q2 2022 Jul 26, 2022	BUY	$66.18 - $83.18 $4.72 Million - $5.93 Million	71,295 Added 10.19%	771,096 $58.6 Million
Q1 2022 Apr 27, 2022	SELL	$66.02 - $79.71 $4.34 Million - $5.24 Million	-65,785 Reduced 8.59%	699,801 $55.6 Million
Q4 2021 Feb 02, 2022	SELL	$63.34 - $74.11 $4.47 Million - $5.23 Million	-70,582 Reduced 8.44%	765,586 $56.2 Million
Q3 2021 Oct 25, 2021	SELL	$68.67 - $84.02 $1.6 Million - $1.96 Million	-23,291 Reduced 2.71%	836,168 $57.5 Million
Q2 2021 Aug 02, 2021	SELL	$79.87 - $87.53 $4.23 Million - $4.63 Million	-52,940 Reduced 5.8%	859,459 $72.3 Million
Q1 2021 Apr 30, 2021	BUY	$76.02 - $100.5 $4.46 Million - $5.89 Million	58,626 Added 6.87%	912,399 $74.2 Million
Q4 2020 Feb 05, 2021	SELL	$80.74 - $97.7 $1.29 Million - $1.56 Million	-16,012 Reduced 1.84%	853,773 $74.3 Million
Q3 2020 Oct 30, 2020	SELL	$85.07 - $109.69 $3.61 Million - $4.65 Million	-42,390 Reduced 4.65%	869,785 $78.1 Million
Q2 2020 Jul 27, 2020	SELL	$74.18 - $108.93 $11.8 Million - $17.3 Million	-159,234 Reduced 14.86%	912,175 $94.8 Million
Q1 2020 Apr 27, 2020	BUY	$63.18 - $85.97 $8.63 Million - $11.7 Million	136,562 Added 14.61%	1,071,409 $78.5 Million
Q4 2019 Jan 31, 2020	BUY	$73.04 - $95.72 $317,504 - $416,094	4,347 Added 0.47%	934,847 $81.6 Million
Q3 2019 Oct 31, 2019	BUY	$72.82 - $86.52 $1.91 Million - $2.27 Million	26,191 Added 2.9%	930,500 $69.1 Million
Q2 2019 Jul 29, 2019	BUY	$73.52 - $88.7 $5.84 Million - $7.04 Million	79,381 Added 9.62%	904,309 $76.8 Million
Q1 2019 May 08, 2019	BUY	$63.56 - $88.17 $3.85 Million - $5.34 Million	60,551 Added 7.92%	824,928 $71 Million
Q4 2018 Feb 06, 2019	BUY	$58.5 - $69.94 $8.02 Million - $9.59 Million	137,094 Added 21.86%	764,377 $47.6 Million
Q3 2018 Nov 07, 2018	BUY	$61.75 - $74.23 $1.35 Million - $1.62 Million	21,869 Added 3.61%	627,283 $43.3 Million
Q2 2018 Aug 01, 2018	BUY	$60.85 - $83.98 $5.98 Million - $8.25 Million	98,219 Added 19.37%	605,414 $40.6 Million
Q1 2018 May 01, 2018	BUY	$83.06 - $100.98 $632,252 - $768,659	7,612 Added 1.52%	507,195 $42.3 Million
Q4 2017 Feb 06, 2018	BUY	$93.56 - $116.6 $623,109 - $776,556	6,660 Added 1.35%	499,583 $47.3 Million
Q3 2017 Nov 07, 2017	SELL	$109.15 - $138.27 $5.17 Million - $6.55 Million	-47,381 Reduced 8.77%	492,923 $57.5 Million
Q2 2017 Aug 07, 2017	BUY	N/A	540,304	540,304 $68 Million

Others Institutions Holding INCY

# of Institutions

629

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Incyte Corp Transaction History